FDA Approves New Vaccine to Prevent Gastroenteritis Caused by Rotavirus

The U.S. Food and Drug Administration announced on April 3, 2008 the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. Rotarix is a liquid and given in a two-dose series to infants from 6 to 24 weeks of age. Click here to read more.

Study Refutes Link Between Thimerosal and Autism

An article in the January issue of the Archives of General Psychiatry, a journal published by the American Medical Association (AMA), refutes the claim that childhood exposure to thimerosal is a cause of autism. Read more, "Continuing Increases in Autism Reported to California's Developmental Services System: Mercury in Retrograde."

Thimerosal and Vaccines

The Utah Immunization Program has proactively purchased thimerosal-free vaccines since 1999, as they have become available. To read an article about Thimerosal and Autism, click here. To learn more about Thimerosal and Vaccines, click [more].

Back to Top